DEXCOM INC — Director's Dealing 2014

Jun 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-05-30

Reporting Person: ALTMAN STEVEN R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-30	Common Stock	A	6462.0	$0.0010	Acquired	22932	Direct

Footnotes

F1: Share units are restricted and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.

F2: Included in this number are 10,708 unvested restricted stock units which were granted on November 4, 2013 and shall vest through November 4, 2016.